How Is Chronic Lymphocytic Leukemia Treated?

This content has been reviewed and approved by

Hagop M. Kantarjian, MD
Chairman & Professor, Leukemia Department
MD Anderson Cancer Center
University of Texas
 

In the early stages, chronic lymphocytic leukemia (CLL) may not need treatment and you may be only observed. Many patients may live their normal life span not needing any treatment. Treatment is generally advised in patients with advanced CLL (Rai stage III-IV), if there is bulky disease (lymph nodes, liver spleen), if they have complications of CLL (infections, immune problems), or if they have significant symptoms caused by CLL, such as fatigue, sweats, fever, weight loss, severe skin itching/lesions, or others.

Specific treatment for CLL will be determined by your physician based on:

  • Your age, overall health, and medical history
  • Extent of the disease
  • Stage of the disease
  • Your tolerance for specific medications, procedures, or therapies
  • Expectations for the course of the disease
  • Your opinion or preference
Treatment may include:
  • Chemotherapy
  • Monoclonal antibodies (Rituxan® [rituximab] or Campath® [alemtuzumab]
  • Treatment for complications, such as infection or anemia
  • Bone marrow transplantation
  • Splenectomy - surgery to remove the spleen
  • Radiation therapy
This content was last modified on August 11, 2007 .
Latest Cancer News
FDA, CDC say Merck's Gardasil shot remains safe

July 22, 2008 — WASHINGTON (Reuters) - A review of health problems reported after women and girls received Merck & Co's Gardasil vaccine shows it remains safe and effective for protecting against infection with a virus that causes cervical cancer, U.S. officials said on Tuesday.

Technology uses tobacco plants to fight cancer

July 22, 2008 — CHICAGO (Reuters) - A personalized vaccine made using tobacco plants -- normally associated with causing cancer rather than helping cure it -- could aid people with lymphoma in fighting the disease, U.S. researchers said on Monday.

New drug helps shrink prostate tumors: study

July 22, 2008 — LONDON (Reuters) - A once-a-day pill significantly shrank tumors in men with advanced prostate cancer who had not responded to other treatments, researchers said on Tuesday.

Select news items provided by Reuters Health